Cue Biopharma Net Asset Quality Index
Cue Biopharma net asset quality index. Cue Biopharma (CUE) has a Net Asset Quality Index of 41.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $31.64 Million minus total liabilities of $18.40 Million yields net assets of $13.25 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Cue Biopharma (CUE) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Cue Biopharma (2015–2024)
Net asset quality index of Cue Biopharma from 2015 to 2024. This chart shows how Cue Biopharma's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the index stands at 41.9%, representing net assets of $13.25 Million against total assets of $31.64 Million USD. Check how strategically is Cue Biopharma's equity deployed to assess the company's strategic physical and investment asset allocation.
Cue Biopharma Net Asset Quality Index by Year (2015–2024)
Cue Biopharma net asset quality index by year from 2015 to 2024. The table below presents the year-by-year Net Asset Quality Index for Cue Biopharma from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CUE stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 54.4% | $17.50 Million | $32.19 Million | $14.69 Million | ▼ -5.9 pp |
| 2023 | 60.3% | $37.09 Million | $61.53 Million | $24.45 Million | ▼ -11.7 pp |
| 2022 | 72.0% | $65.68 Million | $91.28 Million | $25.60 Million | ▼ -6.6 pp |
| 2021 | 78.5% | $65.49 Million | $83.40 Million | $17.91 Million | ▼ -0.8 pp |
| 2020 | 79.3% | $78.91 Million | $99.53 Million | $20.62 Million | ▲ +3.1 pp |
| 2019 | 76.2% | $54.58 Million | $71.61 Million | $17.02 Million | ▲ +1.3 pp |
| 2018 | 74.9% | $33.97 Million | $45.36 Million | $11.39 Million | ▼ -17.1 pp |
| 2017 | 92.0% | $61.61 Million | $66.95 Million | $5.35 Million | ▼ -1.2 pp |
| 2016 | 93.2% | $15.17 Million | $16.28 Million | $1.10 Million | ▼ -1.6 pp |
| 2015 | 94.9% | $6.94 Million | $7.31 Million | $376.30K | — |